|
시장보고서
상품코드
2144800
신속 미생물 검사 시장(2026-2030년)Global Rapid Microbiology Testing Market 2026-2030 |
||||||
세계의 신속 미생물 검사 시장은 2025-2030년 28억 5,940만 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 10.1%를 나타낼 것으로 예측됩니다.
본 보고서는 전 세계 신속 미생물 검사 시장에 대한 종합적인 분석, 시장 규모 및 전망, 동향, 성장 촉진요인, 과제는 물론, 약 25개 업체를 대상으로 한 공급업체 분석을 제공합니다.
본 보고서는 현재 시장 상황, 최신 동향 및 성장요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장을 주도하는 요인은 자동화, 마이크로플루이딕스 기술, AI의 기술적 통합, 항생제 내성 병원체의 급증, 그리고 바이오의약품 제조 분야의 품질 보증 기준입니다.
본 조사는 업계 주요 관계자로부터 얻은 정보를 포함한 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석을 포함한 부문, 그리고 공급업체 현황이 수록되어 있습니다. 보고서에는 과거 데이터 및 예측 데이터가 포함되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준연도 | 2025년 |
| 종료연도 | 2030년 |
| 조사 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| 2026년 전년대비 | 9.7% |
| CAGR | 10.1% |
| 증가액 | 28억 5,940만 달러 |
본 조사에서는 신속한 무균 검사 및 실시간 환경 모니터링의 확대가 향후 몇 년간 전 세계 신속 미생물 검사 시장의 성장을 견인할 주요 요인 중 하나라고 파악하고 있습니다. 또한, 고처리량 자동화 및 통합형 디지털 미생물 검사, 그리고 현장 진단(Point-of-Care) 및 분산형 분자 검출의 가속화가 시장에서 상당한 수요를 창출할 것으로 전망됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 방법별
제9장 시장 세분화 : 최종사용자별
제10장 시장 세분화 : 제품 유형별
제11장 고객 현황
제12장 지역별 상황
제13장 성장 촉진요인, 과제 및 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
LSH 26.10.20The global rapid microbiology testing market is forecasted to grow by USD 2859.4 mn during 2025-2030, accelerating at a CAGR of 10.1% during the forecast period. The report on the global rapid microbiology testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological integration of automation, microfluidics, and ai, surging incidence of antimicrobial-resistant pathogens, quality assurance standards in biopharmaceutical manufacturing.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 9.7% |
| CAGR | 10.1% |
| Incremental Value | $2859.4 mn |
Technavio's global rapid microbiology testing market is segmented as below:
By Method
- Growth-based
- Nucleic-acid based
- Viability-based
- Others
By End-User
- Hospitals and diagnostic laboratories
- Pharmaceutical and biotechnology companies
- Others
By Product Type
- Reagents and kits
- Instruments
- Consumables
Geography
- North America
- US
- Canada
- Mexico
- Asia
- Europe
- Germany
- France
- UK
- Italy
- Spain
- The Netherlands
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the expansion of rapid sterility and real-time environmental monitoring as one of the prime reasons driving the global rapid microbiology testing market growth during the next few years. Also, high-throughput automation and integrated digital microbiology and acceleration of point-of-care and decentralized molecular detection will lead to sizable demand in the market.
The report on the global rapid microbiology testing market covers the following areas:
- Global rapid microbiology testing market sizing
- Global rapid microbiology testing market forecast
- Global rapid microbiology testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global rapid microbiology testing market vendors that include Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Bruker Corp., Charles River Laboratories, COPAN Diagnostics Inc., DiaSorin SpA, Eurofins Scientific SE, Hardy Diagnostics, Hologic Inc., LuminUltra Technologies Ltd, Neogen Corp., QIAGEN N.V., Sartorius AG, Sigma Aldrich Chemicals Ltd., Thermo Fisher Scientific Inc., Veolia Water Technologies. Also, the global rapid microbiology testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Method
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Rapid Microbiology Testing Market 2020 - 2024
- Historic Market Size - Data Table on Global Rapid Microbiology Testing Market 2020 - 2024 ($ million)
- 5.2 Method segment analysis 2020 - 2024
- Historic Market Size - Method Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI in Global Rapid Microbiology Testing Market
- 6.2 Impact of Geopolitical Conflicts on Global Rapid Microbiology Testing Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Method
- 8.1 Market segments
- 8.2 Comparison by Method
- 8.3 Growth-based - Market size and forecast 2025-2030
- 8.4 Nucleic-acid based - Market size and forecast 2025-2030
- 8.5 Viability-based - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by Method
- Market opportunity by Method ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Hospitals and diagnostic laboratories - Market size and forecast 2025-2030
- 9.4 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
- 9.5 Others - Market size and forecast 2025-2030
- 9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Product Type
- 10.1 Market segments
- 10.2 Comparison by Product Type
- 10.3 Reagents and kits - Market size and forecast 2025-2030
- 10.4 Instruments - Market size and forecast 2025-2030
- 10.5 Consumables - Market size and forecast 2025-2030
- 10.6 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Asia - Market size and forecast 2025-2030
- 12.4.1 China - Market size and forecast 2025-2030
- 12.4.2 Japan - Market size and forecast 2025-2030
- 12.4.3 India - Market size and forecast 2025-2030
- 12.4.4 South Korea - Market size and forecast 2025-2030
- 12.4.5 Indonesia - Market size and forecast 2025-2030
- 12.4.6 Thailand - Market size and forecast 2025-2030
- 12.5 Europe - Market size and forecast 2025-2030
- 12.5.1 Germany - Market size and forecast 2025-2030
- 12.5.2 France - Market size and forecast 2025-2030
- 12.5.3 UK - Market size and forecast 2025-2030
- 12.5.4 Italy - Market size and forecast 2025-2030
- 12.5.5 Spain - Market size and forecast 2025-2030
- 12.5.6 The Netherlands - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Technological integration of automation, microfluidics, and AI
- Surging incidence of antimicrobial-resistant pathogens
- Quality assurance standards in biopharmaceutical manufacturing
- 13.2 Market challenges
- High capital acquisition costs and budgetary constraints
- Rigorous regulatory frameworks and stringent validation
- Operational frictions in legacy workflow integration
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Expansion of rapid sterility and real-time environmental monitoring
- High-throughput automation and integrated digital microbiology
- Acceleration of point-of-care and decentralized molecular detection
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.6 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 15.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.8 BioMerieux SA
- BioMerieux SA - Overview
- BioMerieux SA - Business segments
- BioMerieux SA - Key offerings
- BioMerieux SA - Segment focus
- SWOT
- 15.9 Bruker Corp.
- Bruker Corp. - Overview
- Bruker Corp. - Business segments
- Bruker Corp. - Key offerings
- Bruker Corp. - Segment focus
- SWOT
- 15.10 Charles River Laboratories
- Charles River Laboratories - Overview
- Charles River Laboratories - Business segments
- Charles River Laboratories - Key offerings
- Charles River Laboratories - Segment focus
- SWOT
- 15.11 DiaSorin SpA
- DiaSorin SpA - Overview
- DiaSorin SpA - Business segments
- DiaSorin SpA - Key news
- DiaSorin SpA - Key offerings
- DiaSorin SpA - Segment focus
- SWOT
- 15.12 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
- 15.13 Hologic Inc.
- Hologic Inc. - Overview
- Hologic Inc. - Product / Service
- Hologic Inc. - Key offerings
- SWOT
- 15.14 Neogen Corp.
- Neogen Corp. - Overview
- Neogen Corp. - Business segments
- Neogen Corp. - Key offerings
- Neogen Corp. - Segment focus
- SWOT
- 15.15 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.16 Sartorius AG
- Sartorius AG - Overview
- Sartorius AG - Business segments
- Sartorius AG - Key offerings
- Sartorius AG - Segment focus
- SWOT
- 15.17 Sigma Aldrich Chemicals Ltd.
- Sigma Aldrich Chemicals Ltd. - Overview
- Sigma Aldrich Chemicals Ltd. - Product / Service
- Sigma Aldrich Chemicals Ltd. - Key offerings
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
